Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart L Schreiber

Showing results (271-280 of 317) with videos related to

Pageof 32
Sort By:
JCI Insight|July 31, 2019
Antisense oligonucleotides extend survival of prion-infected miceGregory J Raymond, Hien Tran Zhao, Brent Race, et al.
Gigascience|March 23, 2017
A dataset of images and morphological profiles of 30 000 small-molecule treatments using the Cell Painting assayMark-Anthony Bray, Sigrun M Gustafsdottir, Mohammad H Rohban, et al.
Journal of Medicinal Chemistry|September 12, 2014
Diversity-oriented synthesis-facilitated medicinal chemistry: toward the development of novel antimalarial agentsEamon Comer, Jennifer A Beaudoin, Nobutaka Kato, et al.
Nature Biotechnology|March 2, 2016
High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell linesChanning Yu, Aristotle M Mannan, Griselda Metta Yvone, et al.
Nature Chemical Biology|April 2, 2020
Selective covalent targeting of GPX4 using masked nitrile-oxide electrophilesJohn K Eaton, Laura Furst, Richard A Ruberto, et al.
Nature Communications|September 27, 2019
Metabolomic adaptations and correlates of survival to immune checkpoint blockadeHaoxin Li, Kevin Bullock, Carino Gurjao, et al.
Nature Chemical Biology|August 21, 2025
Highly specific intracellular ubiquitination of a small moleculeWeicheng Li, Enrique M Garcia-Rivera, Dylan C Mitchell, et al.
Nature Chemical Biology|December 15, 2015
Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomicsLuc de Waal, Timothy A Lewis, Matthew G Rees, et al.
Nature|September 17, 2020
Plasticity of ether lipids promotes ferroptosis susceptibility and evasionYilong Zou, Whitney S Henry, Emily L Ricq, et al.
Nucleic Acids Research|August 11, 2020
Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpointsEric Vallabh Minikel, Hien T Zhao, Jason Le, et al.
Pageof 32

Showing results (271-280 of 317) with videos related to

Sort By:
Pageof 32
JCI Insight|July 31, 2019
Antisense oligonucleotides extend survival of prion-infected miceGregory J Raymond, Hien Tran Zhao, Brent Race, et al.
Gigascience|March 23, 2017
A dataset of images and morphological profiles of 30 000 small-molecule treatments using the Cell Painting assayMark-Anthony Bray, Sigrun M Gustafsdottir, Mohammad H Rohban, et al.
Journal of Medicinal Chemistry|September 12, 2014
Diversity-oriented synthesis-facilitated medicinal chemistry: toward the development of novel antimalarial agentsEamon Comer, Jennifer A Beaudoin, Nobutaka Kato, et al.
Nature Biotechnology|March 2, 2016
High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell linesChanning Yu, Aristotle M Mannan, Griselda Metta Yvone, et al.
Nature Chemical Biology|April 2, 2020
Selective covalent targeting of GPX4 using masked nitrile-oxide electrophilesJohn K Eaton, Laura Furst, Richard A Ruberto, et al.
Nature Communications|September 27, 2019
Metabolomic adaptations and correlates of survival to immune checkpoint blockadeHaoxin Li, Kevin Bullock, Carino Gurjao, et al.
Nature Chemical Biology|August 21, 2025
Highly specific intracellular ubiquitination of a small moleculeWeicheng Li, Enrique M Garcia-Rivera, Dylan C Mitchell, et al.
Nature Chemical Biology|December 15, 2015
Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomicsLuc de Waal, Timothy A Lewis, Matthew G Rees, et al.
Nature|September 17, 2020
Plasticity of ether lipids promotes ferroptosis susceptibility and evasionYilong Zou, Whitney S Henry, Emily L Ricq, et al.
Nucleic Acids Research|August 11, 2020
Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpointsEric Vallabh Minikel, Hien T Zhao, Jason Le, et al.
Pageof 32